BOOTHBAY FUND MANAGEMENT, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$459,000
+1175.0%
638,600
+3935.9%
0.01%
+1000.0%
Q4 2021$36,000
-83.4%
15,823
-79.0%
0.00%
-83.3%
Q3 2021$217,000
+13.0%
75,240
+48.2%
0.01%0.0%
Q2 2021$192,000
+65.5%
50,772
+48.0%
0.01%
+50.0%
Q1 2021$116,000
+114.8%
34,302
+77.4%
0.00%
+100.0%
Q4 2020$54,000
+3.8%
19,332
-6.2%
0.00%
-33.3%
Q3 2020$52,000
-81.3%
20,620
-71.0%
0.00%
-88.0%
Q3 2019$278,000
-67.4%
71,000
-31.7%
0.02%
-69.9%
Q1 2019$852,000
+134.1%
104,000
+57.9%
0.08%
+56.6%
Q4 2018$364,00065,8520.05%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$10,515,00010.70%
Orchard Capital Management, LLC 1,593,531$3,601,0001.06%
Nantahala Capital Management 4,918,565$11,116,0000.39%
Ardent Capital Management, Inc. 168,811$382,0000.25%
Birchview Capital, LP 100,000$226,0000.15%
Nantahala Capital Management 1,000,000$2,260,0000.08%
PDT Partners, LLC 433,400$979,0000.08%
Woodline Partners LP 2,231,966$5,044,0000.07%
Virtus ETF Advisers LLC 69,015$156,0000.06%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,737,900$6,188,0000.04%
View complete list of AKEBIA THERAPEUTICS INC shareholders